Enzo Biochem Inc's ROA from the third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Enzo Biochem Inc's ROA in the third quarter of 2025?
Enzo Biochem Inc recorded a cumulative net loss of $-21 million during 12 months ending in the third quarter of 2025, resulting in a negative return on assets (ROA) of -26.83%.

However, within the Healthcare sector 451 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Apr 30 2025 quarter, so far to 3840, from total ROA ranking in the second quarter of 2025 at 3870.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Apr 30 2025) III. Quarter	(Jan 31 2025) II. Quarter	(Oct 31 2024) I. Quarter	(Jul 31 2024) IV. Quarter	(Apr 30 2024) III. Quarter
Y / Y Total Assets Change	-31.64 %	-34.33 %	-28.13 %	-23.35 %	52.43 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-21	-21	-23	-26	45
Return On Assets (TTM)	-26.83 %	-24.81 %	-24.21 %	-25.67 %	40.62 %
ENZ's Total Ranking	# 3840	# 3870	# 102	# 132	# 163
Total Assets (TTM) in million	64	65	74	112	93
Seq. Total Assets Change	-1.56 %	-12.99 %	-33.82 %	20.6 %	-5.42 %
Seq. Net Income Change	-	-	-	-	-

ENZ's 5 Years Annual ROA >> Back to ENZ Management Effectiveness >> Compare ENZ ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 52
Sector	# 452
Overall	# 3828

Return On Assets Statistics
High	Average	Low
52.72 %	-8.78 %	-73.09 %
(Jul 31 2016)		(Apr 30 2013)

Financial Statements
Enzo Biochem Inc's Assets	$ 64 million	ENZ's Balance sheet
Enzo Biochem Inc's Income	$ -3 million	Quarterly ENZ's Income Statement
ENZ's Income by Division		See ENZ's Income by Division

Annual Return On Assets	(Jul 31 2024) FY 2024	(Jul 31 2023) FY 2023	(Jul 31 2022) FY 2022	(Jul 31 2021) FY 2021	(Jul 31 2020) FY 2020
Y / Y Total Assets Change	-6.23 %	47.42 %	-17.16 %	2.76 %	-10.69 %
Total Assets in million	112	120	81	98	95
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-26	20	-18	8	-29
Annual Return On Assets	-23.27 %	16.98 %	-22.53 %	8.05 %	-29.95 %

ENZ's 5 Years Annual ROA >> Back to ENZ Management Effectiveness >> Compare ENZ ROA to its Competitors

More Return On Assets Ratios
ENZ's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ENZ's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ENZ's Competitors
Subscribers only: Roa for Enzo Biochem Inc's Suppliers
Subscribers only: Return On Assets for ENZ's Customers

You may also want to know
ENZ's Roi	ENZ's Inventory Turnover Ratio	ENZ's Growth Rates	ENZ's Dividend Comparisons
	ENZ's Profitability Ratios	ENZ's Asset Turnover Ratio	ENZ's Dividend Growth
ENZ's Roe	ENZ's Valuation Ratios	ENZ's Financial Strength Ratios	ENZ's Dividend Payout Ratio

Companies with similar Return On Assets at Apr 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-08T17:35:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.